ArticlePloS one2025
Evaluation of nerve function after Bell's palsy based on different facial nerve assessment scales HBGS/SFGS/MPS: A comparative study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Motor Unit Number Index (MUNIX) as an Early Prognostic Biomarker in Acute Bell's Palsy: A Prospective Cohort Study.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStudies have shown that approximately 30% of patients with Bell's palsy may experience permanent disfigurement due to muscle weakness affecting facial expressions. The prognosis for Bell's palsy is often correlated with the degree of impairment in facial nerve function observed in the early stages of the condition. Selecting appropriate assessment tools is essential for the effective treatment and prognosis of patients with Bell's palsy.
objectiveExamine and compare three scales used to measure Bell's palsy: the House-Brackmann Grading Scale (HBGS), the Sunnybrook Facial Grading System (SFGS), and the Modified Portmann Scale (MPS).
methodsA retrospective study involved 97 patients with Bell's palsy treated at the authors' institution from 2021 to 2022. The authors accessed these data for research purposes in February 2025. The patient cohort underwent HBGS, SFGS, and MPS to assess facial nerve function before and after treatment. We compared the results of these three evaluation methods. Additionally, we performed correlation analyses and receiver operating characteristic (ROC) analyses of the post-treatment data to examine the relationships between HBGS and SFGS and between HBGS and MPS, using the internationally recognized and most widely utilized HBGS as the standard.
resultsThe HBGS demonstrated moderate consistency with both the FSGS and MPS, revealing significant negative correlations (r = -0.876, P < 0.01; r = -0.860, P < 0.01). All three scales exhibited high reactivity and showed no ceiling/floor effect. The optimal cut-off values for the FSGS and MPS were determined to be ≤ 68 and ≤ 16 points, respectively, with AUC of 0.948 (95% CI: 0.910-0.984) and 0.931 (95% CI: 0.883-0.968).
conclusionHBGS, SFGS, and MPS are all appropriate tools for assessing Bell's palsy. The severity of facial nerve palsy can be clinically classified using a transect score of 68 on the SFGS and 16 on the MPS. However, the results should be interpreted with caution, as objective indicators were not utilized as criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.